Andy Kaempf

Oregon Health and Science University

Portland, OR

United States

SCHOLARLY PAPERS

2

DOWNLOADS

103

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia

Number of pages: 57 Posted: 22 Feb 2022
affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, City of Hope, affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University - Department of Molecular and Medical Genetics, Oregon Health & Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, affiliation not provided to SSRN, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon State University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University - OHSU Knight Cancer Center Institute, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health and Science University, University of Florida - Division of Hematology/Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of Colorado Denver, affiliation not provided to SSRN, University of Miami, University of Miami, University of Colorado at Denver - Division of Hematology, University of Utah, University of Miami, University of Kansas Medical Center, Oregon Health and Science University, Oregon Health and Science University and Oregon Health and Science University - Division of Bioinformatics and Computational Biology
Downloads 57 (664,170)

Abstract:

Loading...

hematologic malignancy, targeted therapy, LSC17, cell state, leukemia stem cell, monocyte, eigengene, JEDI, MEGF12

2.

Real-World Comparison of Bleeding and Thrombotic Outcomes in V-V ECMO: Heparin Versus Bivalirudin

Number of pages: 21 Posted: 30 Mar 2023
Oregon Health & Science University, Oregon Health and Science University, Oregon Health & Science University, Oregon Health & Science University, Oregon Health and Science University, Oregon Health & Science University, Oregon Health & Science University, Oregon Health & Science University, Oregon Health & Science University, Oregon Health & Science University, Oregon Health & Science University, Oregon Health and Science University, Oregon Health and Science University, Oregon Health & Science University, Oregon Health and Science University and Oregon Health and Science University - Department of Pulmonary and Critical Care Medicine
Downloads 46 (730,277)

Abstract:

Loading...

anticoagulation, bivalirudin, extracorporeal membrane oxygenation, heparin, thrombosis